Open AccessNovel Panel of Cerebrospinal Fluid Biomarkers for the Prediction of Progression to Alzheimer Dementia in Patients With Mild Cognitive Impairment
Author(s) -
Anja Hviid Simonsen,
J. H. McGuire,
Oskar Hansson,
Henrik Zetterberg,
Vladimir N. Podust,
Huw Davies,
Gunhild Waldemar,
Lennart Minthon,
Kaj Blennow
Publication year - 2007
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.64.3.366
Subject(s) - cerebrospinal fluid , dementia , medicine , cognitive impairment , alzheimer's disease , neuropsychology , oncology , cognition , disease , psychiatry
To use proteomic analysis of cerebrospinal fluid to discover novel proteins and peptides able to differentiate between patients with stable mild cognitive impairment (MCI) and those who will progress to Alzheimer disease (AD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom